179 related articles for article (PubMed ID: 11704863)
21. Active Ras-induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3-kinase activity.
Karasarides M; Dee K; Schulman D; Wolfman A; Weyman CM
Cell Biol Int; 2006 Apr; 30(4):308-18. PubMed ID: 16503174
[TBL] [Abstract][Full Text] [Related]
22. Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K.
Rosseland CM; Wierød L; Flinder LI; Oksvold MP; Skarpen E; Huitfeldt HS
J Cell Physiol; 2008 Jun; 215(3):818-26. PubMed ID: 18163378
[TBL] [Abstract][Full Text] [Related]
23. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
24. Mutant ras-induced proliferation of human thyroid epithelial cells requires three effector pathways.
Bounacer A; McGregor A; Skinner J; Bond J; Poghosyan Z; Wynford-Thomas D
Oncogene; 2004 Oct; 23(47):7839-45. PubMed ID: 15361839
[TBL] [Abstract][Full Text] [Related]
25. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Im JY; Kim J; Choi WS; Kim HS
Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
[TBL] [Abstract][Full Text] [Related]
26. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
[TBL] [Abstract][Full Text] [Related]
28. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
29. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines.
Liou JS; Chen JS; Faller DV
J Cell Physiol; 2004 Feb; 198(2):277-94. PubMed ID: 14603530
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
Nesterov A; Nikrad M; Johnson T; Kraft AS
Cancer Res; 2004 Jun; 64(11):3922-7. PubMed ID: 15173003
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells.
Matesic DF; Villio KN; Folse SL; Garcia EL; Cutler SJ; Cutler HG
Cancer Chemother Pharmacol; 2006 Jun; 57(6):741-54. PubMed ID: 16254733
[TBL] [Abstract][Full Text] [Related]
35. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
36. [Constitutive activity of MAP kinase cascades in REF cells transformed by E1A and cHa-ras oncogenes].
Svetlikova SB; Abramova MV; Kukushkin AN; Darieva ZA; Pospelova TV; Pospelov VA
Tsitologiia; 2001; 43(10):961-8. PubMed ID: 11769129
[TBL] [Abstract][Full Text] [Related]
37. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling.
Lee SG; Su ZZ; Emdad L; Sarkar D; Franke TF; Fisher PB
Oncogene; 2008 Feb; 27(8):1114-21. PubMed ID: 17704808
[TBL] [Abstract][Full Text] [Related]
38. Ha-Ras sensitizes transformed mouse skin cells to Anisomycin-induced apoptosis.
Santibañez JF; Hurtado C
FEBS Lett; 2005 Nov; 579(28):6459-64. PubMed ID: 16288745
[TBL] [Abstract][Full Text] [Related]
39. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling.
Repasky GA; Zhou Y; Morita S; Der CJ
Mol Carcinog; 2007 Dec; 46(12):958-70. PubMed ID: 17477350
[TBL] [Abstract][Full Text] [Related]
40. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
